IL177703A0 - Method of evaluating the therapeutic potential of a vaccine for mucosal administration - Google Patents

Method of evaluating the therapeutic potential of a vaccine for mucosal administration

Info

Publication number
IL177703A0
IL177703A0 IL177703A IL17770306A IL177703A0 IL 177703 A0 IL177703 A0 IL 177703A0 IL 177703 A IL177703 A IL 177703A IL 17770306 A IL17770306 A IL 17770306A IL 177703 A0 IL177703 A0 IL 177703A0
Authority
IL
Israel
Prior art keywords
vaccine
evaluating
therapeutic potential
mucosal administration
mucosal
Prior art date
Application number
IL177703A
Other languages
English (en)
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alk Abello As filed Critical Alk Abello As
Publication of IL177703A0 publication Critical patent/IL177703A0/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
IL177703A 2004-02-26 2006-08-24 Method of evaluating the therapeutic potential of a vaccine for mucosal administration IL177703A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US54845404P 2004-02-26 2004-02-26
DKPA200400310 2004-02-26
US55909504P 2004-04-02 2004-04-02
PCT/DK2005/000123 WO2005083385A2 (en) 2004-02-26 2005-02-24 Method of evaluating the therapeutic potential of a vaccine for mucosal administration

Publications (1)

Publication Number Publication Date
IL177703A0 true IL177703A0 (en) 2006-12-31

Family

ID=34915878

Family Applications (1)

Application Number Title Priority Date Filing Date
IL177703A IL177703A0 (en) 2004-02-26 2006-08-24 Method of evaluating the therapeutic potential of a vaccine for mucosal administration

Country Status (8)

Country Link
EP (1) EP1718974A2 (pt)
JP (1) JP2007524096A (pt)
AU (1) AU2005217696B2 (pt)
BR (1) BRPI0508078A (pt)
CA (1) CA2556557A1 (pt)
IL (1) IL177703A0 (pt)
RU (1) RU2006134031A (pt)
WO (1) WO2005083385A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2006134031A (ru) * 2004-02-26 2008-04-10 Альк-Абелло А/С (Dk) Способ оценки терапевтического потенциала вакцины для введения через слизистые оболочки
EP1974745B1 (en) 2007-03-28 2011-08-31 Alk-Abelló A/S Use of an adjuvanted allergy vaccine formulation for subcutaneous administration
EP1974746B1 (en) * 2007-03-28 2012-01-11 Alk-Abelló A/S Use of an adjuvanted allergy vaccine formulation for parenteral administration
DE202008006598U1 (de) * 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
CN109952510A (zh) 2016-05-13 2019-06-28 应用酵素医学研究所株式会社 收集用于预测过敏发病风险的数据的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992021031A1 (en) * 1991-05-10 1992-11-26 Alain De Weck PROCEDURE FOR DETECTING AND PREPARING ANTI-IgE AUTOANTIBODIES AND USE OF THESE ANTIBODIES AS ACTIVE AGENTS IN DIAGNOSTIC AND THERAPEUTIC COMPOSITIONS
US7888458B1 (en) * 1993-11-30 2011-02-15 John B. Harley Diagnostics and therapy of epstein-barr virus in autoimmune disorders
JP4523156B2 (ja) * 1998-06-24 2010-08-11 アルク−アベル・アー／エス 液体試料中における抗体の検出方法
WO2000040713A1 (en) * 1999-01-06 2000-07-13 Mcmaster University Method of preventing immune and hypersensitivity reactions
SE0004892D0 (sv) * 2000-12-29 2000-12-29 Pharmacia Diagnostics Ab Group 2 allergen specific IgE-Fabs and use thereof
GB0215710D0 (en) * 2002-07-05 2002-08-14 Isis Innovation Diagnostic method
UA62780A (en) * 2003-05-22 2003-12-15 Univ Oo Bohomolets Nat Medical Method for estimating efficiency of vaccination against diphtheria in children with allergic diathesis
RU2006134031A (ru) * 2004-02-26 2008-04-10 Альк-Абелло А/С (Dk) Способ оценки терапевтического потенциала вакцины для введения через слизистые оболочки

Also Published As

Publication number Publication date
AU2005217696B2 (en) 2008-02-14
WO2005083385A3 (en) 2005-11-17
WO2005083385A2 (en) 2005-09-09
JP2007524096A (ja) 2007-08-23
BRPI0508078A (pt) 2007-07-17
EP1718974A2 (en) 2006-11-08
RU2006134031A (ru) 2008-04-10
CA2556557A1 (en) 2005-09-09
AU2005217696A1 (en) 2005-09-09

Similar Documents

Publication Publication Date Title
ZA200804918B (en) Therapeutic vaccine
TWI365191B (en) Vaccine
GB0526291D0 (en) Therapeutic method
IL178971A0 (en) Vaccine for periodontal disease
GB0409940D0 (en) Vaccine
EP1677816A4 (en) THERAPEUTIC METHOD
EP1765387A4 (en) NEUTRAL ADMINISTRATION OF VACCINE AGAINST FELV
HK1214534A1 (zh) 流感疫苗
HK1088259A1 (en) Potential therapeutic apparatus
IL177703A0 (en) Method of evaluating the therapeutic potential of a vaccine for mucosal administration
HK1088260A1 (en) Potential therapeutic apparatus
GB2460969B (en) Vaccines for intranasal administration
GB0411150D0 (en) Vaccine
GB0423800D0 (en) New pharmaceutical formulations
EP1791506A4 (en) DEVICE-ASSISTED DRUG DELIVERY METHOD
GB0413510D0 (en) Vaccine
GB0412407D0 (en) Vaccine
GB0428381D0 (en) Vaccine
GB0420250D0 (en) Method for oral drug delivery
GB0406598D0 (en) Vaccine
GB0419918D0 (en) Vaccine
EP1793848A4 (en) METHOD OF DETERMINING A DOSAGE FOR ORAL INACTIVE VACCINE
GB0420822D0 (en) Therapeutic method
GB0420823D0 (en) Therapeutic method
GB0420828D0 (en) Therapeutic method